Institutional investors hold a majority ownership of EW through the 85.04% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended June 2017, these large investors purchased a net $430.9 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WALTER SCOTT & PARTNERS LTD. Bought 3.4 Million shares of Edwards Lifesciences Corp
EGERTON CAPITAL (UK) LLP Bought 1.8 Million shares of Edwards Lifesciences Corp